| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.18 | 2e-06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.17 | 8e-06 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.23 | 6e-05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |